Literature DB >> 16816931

A case of primary hyperparathyroidism with marked changes in bone mineral density and geometry after parathyroidectomy.

Hiroshi Kaji1, Mei-Fway Iu, Junko Naito, Toshitsugu Sugimoto, Kazuo Chihara.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16816931     DOI： 10.1007/s00774-006-0694-z

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN： 0914-8779            Impact factor:   2.626


× No keyword cloud information.
  20 in total

1.  Changes in geometry and cortical porosity in adult, ovary-intact rabbits after 5 months treatment with LY333334 (hPTH 1-34).

Authors:  T Hirano; D B Burr; R L Cain; J M Hock
Journal:  Calcif Tissue Int       Date:  2000-06       Impact factor: 4.333

2.  Marked improvement in bone mass after parathyroidectomy in osteitis fibrosa cystica.

Authors:  C A Kulak; C Bandeira; D Voss; S M Sobieszczyk; S J Silverberg; F Bandeira; J P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  1998-03       Impact factor: 5.958

3.  The threshold of bone mineral density for vertebral fractures in female patients with primary hyperparathyroidism.

Authors:  Hiroshi Kaji; Mika Yamauchi; Kazuo Chihara; Toshitsugu Sugimoto
Journal:  Eur J Endocrinol       Date:  2005-09       Impact factor: 6.664

4.  Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism.

Authors:  S J Silverberg; F Gartenberg; T P Jacobs; E Shane; E Siris; R B Staron; D J McMahon; J P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  1995-03       Impact factor: 5.958

5.  Primary hyperparathyroidism and the risk of fracture: a population-based study.

Authors:  S Khosla; L J Melton; R A Wermers; C S Crowson; W m O'Fallon; B l Riggs
Journal:  J Bone Miner Res       Date:  1999-10       Impact factor: 6.741

6.  Prediction of bone mass change after parathyroidectomy in patients with primary hyperparathyroidism.

Authors:  D Nakaoka; T Sugimoto; T Kobayashi; T Yamaguchi; A Kobayashi; K Chihara
Journal:  J Clin Endocrinol Metab       Date:  2000-05       Impact factor: 5.958

7.  On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism.

Authors:  D W Dempster; M Parisien; S J Silverberg; X G Liang; M Schnitzer; V Shen; E Shane; D B Kimmel; R Recker; R Lindsay; J P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  1999-05       Impact factor: 5.958

8.  Differential effects of menopause and metabolic disease on trabecular and cortical bone assessed by peripheral quantitative computed tomography (pQCT).

Authors:  K Tsurusaki; M Ito; K Hayashi
Journal:  Br J Radiol       Date:  2000-01       Impact factor: 3.039

9.  A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery.

Authors:  S J Silverberg; E Shane; T P Jacobs; E Siris; J P Bilezikian
Journal:  N Engl J Med       Date:  1999-10-21       Impact factor: 91.245

10.  Marked and sustained increase in bone mineral density after parathyroidectomy in patients with primary hyperparathyroidism; a six-year longitudinal study with or without parathyroidectomy in a Japanese population.

Authors:  Rikako Nomura; Toshitsugu Sugimoto; Tatsuo Tsukamoto; Mika Yamauchi; Hideaki Sowa; Qingxiang Chen; Toru Yamaguchi; Akira Kobayashi; Kazuo Chihara
Journal:  Clin Endocrinol (Oxf)       Date:  2004-03       Impact factor: 3.478
View more
  2 in total

1.  Hungry bone syndrome after parathyroidectomy caused by an ectopic parathyroid adenoma.

Authors:  Ediz Yeşilkaya; Peyami Cinaz; Aysun Bideci; Orhun Camurdan; Fatma Demirel; Sedat Demircan
Journal:  J Bone Miner Metab       Date:  2008-12-05       Impact factor: 2.626

2.  Remarkable increase in lumbar spine bone mineral density and amelioration in biochemical markers of bone turnover after parathyroidectomy in elderly patients with primary hyperparathyroidism: a 5-year follow-up study.

Authors:  Yoshiaki Tamura; Atsushi Araki; Yuko Chiba; Seijiro Mori; Takayuki Hosoi; Toshiyuki Horiuchi
Journal:  J Bone Miner Metab       Date:  2007-06-25       Impact factor: 2.976
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.